Ladenburg analyst Jeffrey Cohen raised the firm’s price target on ChromaDex to $6.70 from $6.40 and keeps a Buy rating on the shares following the Q1 report. The firm expects the company’s e-commerce channel to continue to gain traction, with greater benefit when sales are made directly on the Tur Niagen website.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CDXC: